Maple Capital Management, Inc. Danaher Corp Transaction History

Maple Capital Management, Inc.

$1.31 Billion
Q3 2024

A detailed history of Maple Capital Management, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Maple Capital Management, Inc. holds 19,712 shares of DHR stock, worth $4.88 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

19,712

Previous 23,505 16.14%

Holding current value

$4.88 Million

Previous $5.87 Million 6.69%

% of portfolio

0.42%

Previous 0.48%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$239.25 - $280.76 $907,475 - $1.06 Million	-3,793 Reduced 16.14%	19,712 $5.48 Million
Q2 2024 Jul 30, 2024	SELL	$235.51 - $267.98 $7.13 Million - $8.11 Million	-30,268 Reduced 56.29%	23,505 $5.87 Million
Q1 2024 May 09, 2024	SELL	$224.58 - $256.19 $188,422 - $214,943	-839 Reduced 1.54%	53,773 $13.4 Million
Q4 2023 Feb 07, 2024	SELL	$185.1 - $233.13 $180,102 - $226,835	-973 Reduced 1.75%	54,612 $12.6 Million
Q3 2023 Oct 10, 2023	SELL	$233.08 - $265.59 $507,415 - $578,189	-2,177 Reduced 3.77%	55,585 $13.8 Million
Q2 2023 Jul 14, 2023	SELL	$224.99 - $256.14 $925,158 - $1.05 Million	-4,112 Reduced 6.65%	57,762 $13.9 Million
Q1 2023 May 02, 2023	SELL	$239.75 - $277.0 $608,485 - $703,026	-2,538 Reduced 3.94%	61,874 $15.6 Million
Q4 2022 Feb 13, 2023	SELL	$241.42 - $282.29 $337,263 - $394,359	-1,397 Reduced 2.12%	64,412 $17.1 Million
Q3 2022 Nov 15, 2022	SELL	$247.06 - $1507.4 $184,059 - $1.12 Million	-745 Reduced 1.12%	65,809 $17.6 Million
Q2 2022 Aug 02, 2022	SELL	$237.11 - $299.66 $575,465 - $727,274	-2,427 Reduced 3.52%	66,554 $16.9 Million
Q1 2022 May 17, 2022	SELL	$257.27 - $315.76 $740,680 - $909,073	-2,879 Reduced 4.01%	68,981 $20.2 Million
Q4 2021 Feb 15, 2022	SELL	$292.08 - $329.01 $1.48 Million - $1.66 Million	-5,054 Reduced 6.57%	71,860 $23.6 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $431,452 - $526,901	-1,585 Reduced 2.02%	76,914 $23.4 Million
Q2 2021 Aug 16, 2021	BUY	$225.08 - $271.69 $231,607 - $279,569	1,029 Added 1.33%	78,499 $24.7 Million
Q1 2021 May 14, 2021	BUY	$212.38 - $245.9 $60,528 - $70,081	285 Added 0.37%	77,470 $17.4 Million
Q4 2020 Feb 12, 2021	SELL	$212.5 - $245.46 $520,412 - $601,131	-2,449 Reduced 3.08%	77,185 $17.1 Million
Q3 2020 Nov 16, 2020	SELL	$177.16 - $215.33 $576,655 - $700,899	-3,255 Reduced 3.93%	79,634 $18.7 Million
Q2 2020 Aug 12, 2020	SELL	$128.7 - $176.83 $532,174 - $731,192	-4,135 Reduced 4.75%	82,889 $14.7 Million
Q1 2020 May 14, 2020	SELL	$121.39 - $169.05 $63,972 - $89,089	-527 Reduced 0.6%	87,024 $12 Million
Q4 2019 Feb 13, 2020	BUY	$133.47 - $153.48 $141,878 - $163,149	1,063 Added 1.23%	87,551 $13.4 Million
Q3 2019 Nov 14, 2019	SELL	$135.4 - $146.47 $427,457 - $462,405	-3,157 Reduced 3.52%	86,488 $12.5 Million
Q2 2019 Aug 14, 2019	BUY	$124.88 - $143.73 $44,831 - $51,599	359 Added 0.4%	89,645 $12.8 Million
Q1 2019 May 15, 2019	SELL	$97.62 - $132.29 $69,700 - $94,455	-714 Reduced 0.79%	89,286 $11.8 Million
Q4 2018 Feb 14, 2019	BUY	$94.85 - $109.54 $89,159 - $102,967	940 Added 1.06%	90,000 $9.28 Million
Q3 2018 Nov 14, 2018	SELL	$98.13 - $108.9 $6,378 - $7,078	-65 Reduced 0.07%	89,060 $0
Q2 2018 Aug 08, 2018	BUY	$96.1 - $103.24 $148,474 - $159,505	1,545 Added 1.76%	89,125 $0
Q1 2018 May 11, 2018	BUY	$92.16 - $103.8 $6.12 Million - $6.89 Million	66,380 Added 313.11%	87,580 $0
Q4 2017 Feb 15, 2018	BUY	$85.26 - $94.62 $885,425 - $982,628	10,385 Added 96.02%	21,200 $1.97 Million
Q3 2017 Nov 03, 2017	BUY	$79.29 - $88.45 $857,521 - $956,586	10,815	10,815 $928,000

Others Institutions Holding DHR

# of Institutions

2,439

Shares Held

562M

Call Options Held

3.94M

Put Options Held

4.11M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $180B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maple Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maple Capital Management, Inc. with notifications on news.

Account

Maple Capital Management, Inc. Danaher Corp Transaction History